Nexalin Technology (NXL) Cash & Equivalents (2021 - 2026)

Nexalin Technology's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 94.19% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 94.19% YoY), while the FY2025 annual figure was $3.1 million, up 434.12% from the prior year.
• Cash & Equivalents was $1.2 million for Q1 2026 at Nexalin Technology, down from $3.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $7.9 million in Q3 2022 to a low of $81421.0 in Q3 2024.
• Historically, Cash & Equivalents has averaged $2.6 million across 5 years, with a median of $1.6 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents sank 95.4% in 2023, then soared 4521.17% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $6.8 million in 2022, then tumbled by 65.33% to $2.4 million in 2023, then slumped by 75.74% to $574485.0 in 2024, then surged by 434.12% to $3.1 million in 2025, then slumped by 60.63% to $1.2 million in 2026.
• The last three Cash & Equivalents figures came in at $1.2 million (Q1 2026), $3.1 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.